Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer - Concepedia

Concepedia

Publication | Open Access

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

DOI Full Paper Access

94

Citations

13

References

2013

Year

Derek J. Jonker, Christos S. Karapetis, Christopher Harbison, Christopher J. O’Callaghan, Dongsheng Tu, R. J. Simes, Daniel P. Malone, Christiane Langer, Niall C. Tebbutt, Timothy Price,

British Journal of Cancer

Epiregulin Gene ExpressionMedicineImmunologyPathologyColorectal CancerCancer GenomicsAdvanced Colorectal CancerOncologyTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1

Page 1